Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DYNLRB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZNF625-ZNF20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
COA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HBG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM49B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCDH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FLJ33360 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CASC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTNNA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CRTAM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
FOLR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TPSB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXL20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CALCR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FPGS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MFSD2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PROCA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on